awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41735562-B30EB5CB-CE9C-4516-8A56-3DE158E5E970
Q41735562-B30EB5CB-CE9C-4516-8A56-3DE158E5E970
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41735562-B30EB5CB-CE9C-4516-8A56-3DE158E5E970
Outcomes from second-line therapy in long-term responders to first-line tyrosine kinase inhibitor in clear-cell metastatic renal cell carcinoma.
P2860
Q41735562-B30EB5CB-CE9C-4516-8A56-3DE158E5E970
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41735562-B30EB5CB-CE9C-4516-8A56-3DE158E5E970
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c6fe24e63aad4239cb20e4530e78c58ccaec7afc
P2860
The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients